Immuron Secures Exclusive Distribution Deal for Irritable Bowel Syndrome Product; Shares Down 3%

MT NewswiresMar 4 21:58 ET

Immuron Ltd: Appendix 4D and Half Year Report

ASXFeb 28 01:48 ET · Announcements

Immuron Partners With Monash University on Antimicrobial Resistance Research; Shares Down 12%

MT NewswiresJan 14 22:11 ET

Immuron Progresses Development of Traveller's Diarrhea Drug Travelan

The Market HeraldJan 13 23:55 ET

Immuron's Travelan Sales Climb 13% in September Quarter; Shares Up 4%

MT NewswiresOct 15, 2024 00:58 ET

Immuron Making Inroads Into the International Market With Flagship Assets Travelan and IMM-529

Investing.com Oct 10, 2024 23:08 ET